Outcome Measures for Clinical Trials in Down Syndrome

Increasingly individuals with intellectual and developmental disabilities, including Down syndrome, are being targeted for clinical trials. However, a challenge exists in effectively evaluating the outcomes of these new pharmacological interventions. Few empirically evaluated, psychometrically sound...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Intellect Dev Disabil
Main Authors: Esbensen, Anna J., Hooper, Stephen R., Fidler, Deborah, Hartley, Sigan, Edgin, Jamie, d’Ardhuy, Xavier Liogier, Capone, George, Conners, Frances, Mervis, Carolyn B., Abbeduto, Leonard, Rafii, Michael, Krinsky-McHale, Sharon J., Urv, Tiina
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424621/
https://ncbi.nlm.nih.gov/pubmed/28452584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1352/1944-7558-122.3.247
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados